ClinicalTrials.gg
RecruitingNCT07423988ALTISOMUpdated Apr 8, 2026

Evaluation of Changes in Sleep Efficiency Among PIC DU MIDI Staff Between Nights Spent at Home and Nights Spent in the Workplace Under High Altitude Conditions

An interventional study of Sleep recording in Sleep Disorder (Disorder), sponsored by University Hospital, Toulouse. Recruiting at 1 site in France. Open to participants aged 18 Years to 65 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-04-08.

Sponsored by University Hospital, Toulouse · Not applicable, Interventional, and Prevention

How we know

From the registry’s dates

  • Started Mar 2026; still recruiting 7 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
32
Allocation
Non-randomized
Ages
18 Years to 65 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 65 studies in Sleep Wake Disorders with a site in France — 22 open to participants now, 27 under way, 4 of them phase 3. Sleep Wake Disorders · France.

Planned enrollment
36th of 42
32 · median 87
Started
2026
with 8 others
No phase
29 of 65
11 open now
Primary completion
2027-02
later than 15 of 26 live
Registered
57th of 65
by date

Among the 65 studies in Sleep Wake Disorders with a site in France, this one is the 36th largest by planned enrollment of the 42 interventional ones that give a count, is one of 9 that started in 2026, is one of 29 with no phase, reaches primary completion later than 15 of the 26 other live ones, and was the 57th registered.

Sleep Wake Disorders

747 studies on the registry are indexed under Sleep Wake Disorders; 181 are open to participants now.

Browse Sleep Wake Disorders studies →

Open to participants now

22 of the 65 studies in Sleep Wake Disorders with a site in France are open now. Recruiting first, the newest first:

16 more — sign in →

All 22 open studies →

A study can be open while its sites in France have not opened yet or have stopped. Only those recruiting at a site in France →

Who these studies take

Of the 114 Sleep Wake Disorders studies recruiting now, 40 (35%) set no upper age limit and 53 (46%) stop at 75 or younger; 22 take children under 18; 28 take healthy volunteers.

This study: 18 Years to 65 Years · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 65 studies in Sleep Wake Disorders with a site in France, or all of them as a file.
02

Study summary

Sleep organization and cardiorespiratory parameters are disrupted in extreme conditions such as high altitude. The pathophysiology of medical problems related to acute high-altitude exposure is partially understood, but sleep quality indicators are very rarely measured under these conditions. This lack of information is even more pronounced among employees subjected to cyclical exposure to high-altitude hypoxic stress, as is the case for the employees at the Pic du Midi. These 32 employees regularly report to their occupational physician difficulties in managing their sleep disorders, struggling to distinguish symptoms from objective changes in their sleep cycles. Among them, 13 are on call at the summit of the Pic du Midi (2,877 m), while 19 work there during the day and return home to a lower altitude at night to sleep. The investigators also wish to measure structural changes in sleep and its cardiorespiratory parameters using polysomnography in these 13 employees, comparing nights spent at home at normal altitude with those spent at the summit of the Pic du Midi. These changes will also be compared to those of a group of 19 employees who do not sleep at high altitude..

03

Conditions studied

  • Sleep Disorder (Disorder)

Keywords

  • sleep
  • high altitude
  • sleep disorder
  • cardiorespiratory parameters
04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

Group "with on-call night at high altitude at the Pic du Midi":

  • Employed at the Pic du Midi for at least one month
  • Working nights at high altitude (at the Pic du Midi, altitude of 2877m) as part of their professional activity
  • Person affiliated with or covered by a social security scheme
  • Free, informed, and written consent signed by the participant and the investigator

Night group "without on-call night at high altitude":

  • Employed at the Pic du Midi for at least one month
  • Not working nights at high altitude (at the Pic du Midi, altitude of 2877m) as part of their professional activity
  • Person affiliated with or covered by a social security scheme social
  • Free, informed and written consent signed by the participant and the investigator

Exclusion criteria

Exclusion Criteria:

  • For all participants:
  • History of cardiovascular disease
  • Use of cardiovascular/psychotropic medication
  • Participant under legal guardianship or other protective regime (guardianship, curatorship)
  • Pregnant or breastfeeding woman
  • French language proficiency insufficient to complete the questionnaires
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Non-randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
32 participants (estimated)

Study arms

  • Experimental
    group with overnight on-call duty at high altitude at the Pic du Midi

    employees of the Pic du Midi who spend the night at high altitude

    Other: Sleep recording

  • Active comparator
    group without night duty at high altitude

    employees of the Pic du Midi who spend the night at home in the plain

    Other: Sleep recording

Interventions

  • OtherSleep recording

    Polysomnography and questionnaires.

06

What researchers measure

Primary outcomes

  1. Comparison of sleep efficiency (total sleep time / total sleep period) under high altitude conditions (at 2877 m) versus without increased altitude (at home)

    Sleep efficiency will be compared, according to the ratio = total sleep time (TST)/ total sleep period (PTS) calculated from a polysomnographic recording, between the night spent at high altitude (2877m, at PIC du MIDI) and the second night spent at home (not increased altitude) among PIC du MIDI employees performing on-call nights at high altitude.

    Time frame: 1 week after the inclusion

Secondary outcomes

  1. Comparison of sleep parameters in high altitude conditions versus without increased altitude for the group "with on-call night at high altitude at Pic du Midi"

    Sleep parameters (determined according to the criteria of the American Academy of Sleep Medicine (AASM)) measured from a polysomnographic recording will be compared in high altitude conditions versus without increased altitude.

    Time frame: 1 week after the inclusion

  2. Measurement of sleep parameters in low altitude conditions for the group "without on-call nights at high altitude"

    Sleep parameters (determined according to the criteria of the American Academy of Sleep Medicine (AASM)) will be measured from a polysomnographic recording under conditions without altitude gain.

    Time frame: 1 week after the inclusion

  3. Evaluation of the relationship between sleep quantification criteria and sleep disorder criteria

    Comparison of questionnaire responses and polysomnographic recording

    Time frame: 1 week after the inclusion

  4. Correlation between cardiac parameters and sleep efficiency.

    Correlation between heart rate variability and sleep efficiency using polysomnography recording

    Time frame: 1 week after the inclusion

  5. Comparison of sleep parameters, in conditions without increased altitude, between the 2 groups of participants

    Comparison of sleep parameters (determined according to the criteria of the American Academy of Sleep Medicine (AASM)) from the polysomnography recording between the two groups in conditions without increased altitude

    Time frame: 1 week after the inclusion

07

Study locations

1 of 1 sites recruiting
  • Unité du sommeil, Hôpital Pierre Paul Riquet, 1 place du Docteur Baylac
    Toulouse, Oui 31059, France
    Recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Mar 2026 (actual). Primary completion is estimated for Feb 2027, 10 months after the start.

Of 214 non-industry interventional studies with no phase under Sleep Wake Disorders, half reached primary completion within 21 months of starting (the median), counting those still running; a quarter within 7 and three quarters within 40. This study's planned 10 months is below that.

Counting every sponsor, half of 249 studies reached it within 19 months; a quarter within 6 and three quarters within 37.

How these figures are worked out, and which studies are left out of them.

Registered
Jan 8, 2026
First posted
Feb 20, 2026
StartActual
Mar 23, 2026
Primary completionEst.
Feb 1, 2027
CompletionEst.
Feb 28, 2027
Last update
Apr 8, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Apr 8, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07423988
Responsible party
Sponsor
First posted
Feb 20, 2026
Start date
Mar 23, 2026
Primary completion
Feb 1, 2027 (estimated)
Completion
Feb 28, 2027 (estimated)
Last update
Apr 8, 2026

Study contacts

Rachel DEBS, MD
Contact
debs.r@chu-toulouse.fr
05 61 77 94 88 ext. + 33

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion